4 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Ambry Genetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers Standard Genetic Counseling, Educational Video - Breast Cancer, Ovarian Cancer | Not applicable | Completed | Dana-Farber Cancer Institute | 269 | 2020-12-01 | 2024-01-19 |
| COVID-19 and SARS-CoV-2 Detection in Saliva RT-PCR - RNA Virus Infections | Completed | Ambry Genetics | 67 | 2020-05-21 | 2022-03-07 | |
| Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer Breast Cancer Risk | Completed | Ambry Genetics | 118 | 2018-09-21 | 2022-03-07 | |
| Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer Multi-gene Next Generation Sequencing Panel - Pancreatic Ductal Adenocarcinoma | Completed | Ambry Genetics | 300 | 2016-05-04 | 2020-08-25 |
Breast Neoplasms (2) · Genetic Risk Score (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · RNA Virus Infections (1)
COVID-19 Nucleic Acid Testing (1)
United States (4)
Brigette Tippin Davis, PhD (1) · Brigette Tippin-Davis, PhD (1) · Erkut Borazanci, MD (1) · Huma Rana, MD (1) · Nadine Tung, MD (1) · Randall Brand, MD (1)